Mark A Pallansch Selected Research

Inactivated Poliovirus Vaccine (Salk Vaccine)

10/2018	Immune Priming and Long-term Persistence of Memory B Cells After Inactivated Poliovirus Vaccine in Macaque Models: Support for at least 2 Doses.
1/2017	Immunogenicity to poliovirus type 2 following two doses of fractional intradermal inactivated poliovirus vaccine: A novel dose sparing immunization schedule.
11/2015	Early priming with inactivated poliovirus vaccine (IPV) and intradermal fractional dose IPV administered by a microneedle device: A randomized controlled trial.
6/2015	Modeling options to manage type 1 wild poliovirus imported into Israel in 2013.
4/2013	Preeradication vaccine policy options for poliovirus infection and disease control.
4/2013	Modeling population immunity to support efforts to end the transmission of live polioviruses.
12/2004	Population immunity to polioviruses among preschool children from four urban underserved low income communities, United States, 1997-2001.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mark A Pallansch Research Topics

Disease

54	Poliomyelitis (Polio) 05/2021 - 09/2003
5	Infections 01/2017 - 09/2008
3	acute flaccid myelitis 01/2017 - 10/2003
2	COVID-19 11/2021 - 04/2021
2	Communicable Diseases (Infectious Diseases) 01/2018 - 07/2013
1	Persistent Infection 01/2020
1	Human Influenza (Influenza) 01/2018
1	Whooping Cough (Pertussis) 01/2018
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2018
1	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2018
1	Pneumonia (Pneumonitis) 01/2018
1	Neoplasms (Cancer) 01/2018
1	Meningococcal Meningitis 01/2018
1	Paralysis (Palsy) 01/2017
1	Asthma (Bronchial Asthma) 11/2015
1	Primary Immunodeficiency Diseases 09/2015
1	Bacterial Meningitis 02/2015
1	Bacterial Infections (Bacterial Infection) 02/2015
1	Japanese Encephalitis 02/2015
1	Cholera 07/2013
1	Influenza in Birds (Avian Flu) 07/2013
1	Reinfection 04/2013
1	Encephalitis (Encephalitis, Rasmussen) 03/2013
1	Vaccine-Preventable Diseases 06/2010
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 02/2009
1	Myocarditis (Carditis) 09/2007
1	IgA Deficiency 01/2004
1	IgG Deficiency 01/2004

Drug/Important Bio-Agent (IBA)

43	VaccinesIBA 11/2021 - 09/2003
22	Oral Poliovirus Vaccine (Sabin Vaccine)IBA 11/2021 - 10/2004
7	Inactivated Poliovirus Vaccine (Salk Vaccine)FDA Link 10/2018 - 12/2004
5	Poliovirus VaccinesIBA 01/2012 - 12/2006
3	AntibodiesIBA 01/2016 - 06/2007
2	Capsid Proteins (Capsid Protein)IBA 01/2020 - 05/2014
2	Antiviral Agents (Antivirals)IBA 01/2017 - 09/2015
2	Immunoglobulin A (IgA)IBA 01/2016 - 05/2014
2	Pharmaceutical PreparationsIBA 09/2015 - 07/2013
2	WastewaterIBA 09/2008 - 10/2003
1	Complement System Proteins (Complement)IBA 01/2017
1	Viral VaccinesIBA 01/2017
1	Immunoglobulin M (IgM)IBA 01/2016
1	SuspensionsIBA 05/2014
1	SilverIBA 07/2013
1	EmulsionsIBA 01/2011
1	Vitamin A (Retinol)FDA LinkGeneric 12/2010
1	Nucleic AcidsIBA 09/2008
1	ElementsIBA 01/2008
1	ParaffinIBA 09/2007
1	Immunoglobulin G (IgG)IBA 01/2004

Therapy/Procedure

1	Immunotherapy 01/2017
1	Critical Care (Surgical Intensive Care) 11/2015
1	Mechanical Ventilators (Ventilator) 11/2015
1	Mass Drug Administration 09/2003